222 related articles for article (PubMed ID: 20676120)
1. Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.
Chen L; Chan TH; Guan XY
Acta Pharmacol Sin; 2010 Sep; 31(9):1165-71. PubMed ID: 20676120
[TBL] [Abstract][Full Text] [Related]
2. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.
Wong N; Chan A; Lee SW; Lam E; To KF; Lai PB; Li XN; Liew CT; Johnson PJ
J Hepatol; 2003 Mar; 38(3):298-306. PubMed ID: 12586295
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
Ma NF; Hu L; Fung JM; Xie D; Zheng BJ; Chen L; Tang DJ; Fu L; Wu Z; Chen M; Fang Y; Guan XY
Hepatology; 2008 Feb; 47(2):503-10. PubMed ID: 18023026
[TBL] [Abstract][Full Text] [Related]
4. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
[TBL] [Abstract][Full Text] [Related]
7. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance].
Li JT; Liu W; Kuang ZH; Chen HK; Li DJ; Feng QS; Liu QC; Hu B
Ai Zheng; 2003 Jul; 22(7):695-9. PubMed ID: 12866958
[TBL] [Abstract][Full Text] [Related]
8. Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.
Eriksson P; Aine M; Sjödahl G; Staaf J; Lindgren D; Höglund M
PLoS One; 2013; 8(6):e67222. PubMed ID: 23825644
[TBL] [Abstract][Full Text] [Related]
9. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.
Mesquita B; Lopes P; Rodrigues A; Pereira D; Afonso M; Leal C; Henrique R; Lind GE; Jerónimo C; Lothe RA; Teixeira MR
Breast Cancer Res Treat; 2013 Feb; 138(1):37-45. PubMed ID: 23329352
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.
Kim TM; Yim SH; Shin SH; Xu HD; Jung YC; Park CK; Choi JY; Park WS; Kwon MS; Fiegler H; Carter NP; Rhyu MG; Chung YJ
Int J Cancer; 2008 Dec; 123(12):2808-15. PubMed ID: 18803288
[TBL] [Abstract][Full Text] [Related]
11. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
[TBL] [Abstract][Full Text] [Related]
12. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
[TBL] [Abstract][Full Text] [Related]
13. Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis.
Nishimura T; Nishida N; Itoh T; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Genes Chromosomes Cancer; 2005 Jan; 42(1):34-43. PubMed ID: 15495198
[TBL] [Abstract][Full Text] [Related]
14. Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.
Burroughs Garcìa J; Eufemiese RA; Storti P; Sammarelli G; Craviotto L; Todaro G; Toscani D; Marchica V; Giuliani N
Cells; 2021 Jun; 10(6):. PubMed ID: 34205916
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
Lau SH; Guan XY
Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
[TBL] [Abstract][Full Text] [Related]
16. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
[TBL] [Abstract][Full Text] [Related]
17. Transgenic CHD1L expression in mouse induces spontaneous tumors.
Chen M; Huang JD; Hu L; Zheng BJ; Chen L; Tsang SL; Guan XY
PLoS One; 2009 Aug; 4(8):e6727. PubMed ID: 19701453
[TBL] [Abstract][Full Text] [Related]
18. CD1d gene is a target for a novel amplicon at 1q22-23.1 in human hepatocellular carcinoma.
Zhang SG; Song WQ; Gao YT; Yang B; Du Z
Mol Biol Rep; 2010 Jan; 37(1):381-7. PubMed ID: 19757161
[TBL] [Abstract][Full Text] [Related]
19. Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma.
Hanamura I
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445467
[TBL] [Abstract][Full Text] [Related]
20. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
